NeuroQore

Executive Summary

NeuroQore is a private, early-stage neuromodulation company based in Cambridge, MA, founded in 2021. The company is developing pioneering treatments for neurobehavioral conditions, with a primary focus on major depressive disorder (MDD) and suicidality. By leveraging advanced neuromodulation techniques and collaborating with world-class research institutions and clinics, NeuroQore aims to address the significant unmet need in these devastating disorders, where current therapies often fall short. The team comprises passionate scientists, engineers, and clinicians dedicated to transforming patient lives through innovative, non-invasive or minimally invasive brain stimulation approaches.

Upcoming Catalysts (preview)

• TBDPreclinical Proof-of-Concept Data for Lead MDD Program30% success
• TBDSeries A Financing Round50% success
• TBDKey Academic Partnership or Collaboration Announcement60% success